You're signed outSign in or to get full access.
Checkpoint Capital L.P.
Checkpoint Capital L.P. is an Austin, Texas-based investment firm specializing in transparent pricing and portfolio management technology solutions for community banks and credit unions. The firm helps smaller financial institutions gain access to investment opportunities and technology previously available only to large banks, offering services such as Asset Liability Management, Bond Portfolio Accounting, and liquidity stress testing. Founded to empower community bankers, Checkpoint aligns its interests with clients and prioritizes full disclosure and transparency in its pricing and operations. The firm employs fewer than 25 people and primarily serves the community banking industry.
Investment Strategy
Checkpoint Capital's investment strategy is primarily long-only, focusing on businesses located in the United States and Europe. The firm employs technology-driven portfolio management and provides access to fixed income investments with a focus on price transparency, cost efficiency, and risk management. It leverages institutional platforms and bypasses commission-driven sales processes, aligning its interests with those of its clients. The firm seeks to maximize income and yield for community banks by offering sophisticated investment resources and direct institutional relationships typically available to large financial institutions.
Latest 13F Filing Activity
Checkpoint Capital L.P. filed their most recent 13F report on Jun 30, 2025 disclosing 8 equity positions with a total 13F market value of $215M. The fund increased holdings in Corcept Therapeutics Inc., Rhythm Pharmaceuticals Inc., Argenx SE among other positions. Checkpoint Capital L.P. reduced exposure to Soleno Therapeutics Inc., Stoke Therapeutics Inc., Protagonist Therapeutics Inc. among others.
Top Holdings
Equity Positions (8)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ARGX | ARGENX SE | 38.52% | $82.7M | 149,977 | $464.54 | $551.22 | +$14.6M |
R RYTM | RHYTHM PHARMACEUTICALS INC | 31.21% | $67.0M | 1,060,000 | $49.82 | $63.19 | +$18.9M |
C CORT | CORCEPT THERAPEUTICS INC | 11.76% | $25.2M | 343,917 | $73.99 | $73.40 | +$24.7M |
I IRON | DISC MEDICINE INC | 6.54% | $14.0M | 265,000 | $58.14 | $52.96 | +$2.0M |
R RVMD | REVOLUTION MEDICINES INC | 4.80% | $10.3M | 280,000 | $39.85 | $36.79 | -$3.6M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more